Publication | Closed Access

Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors

Health SciencesOncologic ImagingMedicineImmune Checkpoint InhibitorsPathologyAdvanced Nsclc PatientsImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyFdg Pet/ct